Breaking

OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B A special team beats brilliant individuals - how silky Spain flattened France 3 teens arrested after acid attack on 6 women in New Jersey ‘Den of spies’: why has Japan been easy prey for Russian espionage, and what is Tokyo doing about it? AL 3B Caminero hit by pitch, exits in 3rd inning Darline Graham is sworn in as senator to fill her brother Lindsey Graham’s seat ‘We’re all going to die’: Scottie Scheffler keeps things in perspective before Open defence Sam Neill’s final films tell us a lot about who he was as an actor – and why we’ll miss him | Luke Buckmaster Cyclospora outbreaks causing diarrhea in US expected to continue through August Google faces another AI training lawsuit from major publishers

NEWSREEL

The day, in 30-second reels.

--:--:--

Tech / Reel

Tech · Video brief

Video generation startup PixVerse raises $439M, valuation soars past $2B

PixVerse, a Singapore-based video generation startup, has successfully raised $439 million, pushing its valuation past $2 billion. With backing from Alibaba and various venture capital firms, the company aims to expand globally and launch n...

TechCrunch· Jul 14, 2026 · 12:56 AM · 11 views

Video won't play? Watch on YouTube →

PixVerse, a Singapore-based video generation startup, has successfully raised $439 million, pushing its valuation past $2 billion. With backing from Alibaba and various venture capital firms, the company aims to expand globally and launch new products. Full story and more reels: https://newsreel.video #news #breaking #startup #investment #technology #PixVerse #videoGeneration

Originally reported by TechCrunch. Read the full story →

More in Tech

OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B

TechCrunch· 2 hours ago

Google faces another AI training lawsuit from major publishers

TechCrunch· 8 hours ago

DeepMind CEO calls for an independent standards body to regulate frontier AI

TechCrunch· 9 hours ago

0 Comments

No comments yet. Be the first.